You're viewing a public preview of this transaction Sign up free to access full investor details, deal amounts & seller data
Sign Up Free Log In
Deal Overview

Cortex Pharmaceuticals - AMPAKINE Compounds (Divestiture, in 2010)

Transaction #78180
Investor
1
Sign up to view
Target Company
Cortex Pharmaceuticals - AMPAKINE Compounds
Life Science · United States
Seller
1
Sign up to view
10 USD
Deal Value
26 Mar 2010
Announced
Target Company
Company Sector Entity Type Status State Country
Cortex Pharmaceuticals - AMPAKINE Compounds Life Science Private Inactive California (CA) United States
Investors 1
InvestorInvestment TypeAmount% Holding
View 1 Investor
Sign up to access investor names, investment types, deal amounts and ownership percentages
Sign Up Free Log In
Sellers 1
Seller
View 1 Seller
Sign up free to access seller names and full exit details for this transaction
Sign Up Free Log In
Frequently Asked Questions
What is the Cortex Pharmaceuticals - AMPAKINE Compounds acquisition deal?
This transaction is an acquisition of Cortex Pharmaceuticals - AMPAKINE Compounds (Divestiture) in 2010. The target company operates in the Life Science sector. Full deal details are available on AcquityData.
When did the Cortex Pharmaceuticals - AMPAKINE Compounds acquisition happen?
This transaction was announced on 26 Mar 2010.
What is the deal value of the Cortex Pharmaceuticals - AMPAKINE Compounds acquisition?
The deal value for this transaction is 10 USD.
Who are the investors in the Cortex Pharmaceuticals - AMPAKINE Compounds transaction?
This transaction has 1 investor. Sign up to AcquityData to view investor names, investment types, amounts and ownership details.

Access the full Cortex Pharmaceuticals - AMPAKINE Compounds deal profile

Unlock investor names, amounts, seller details and complete M&A intelligence in one connected platform.

Start Free Trial